Circe Biomedical

Business Services · 11-50 Employees

View Company Info for Free

Overview

Phone Number

(781) 863-8720

Revenue

<$5 Million

Industry

Business Services Manufacturing Pharmaceuticals Research & Development Medical Devices & Equipment
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Circe Biomedical

Circe Biomedical is a privately held biomedical company focused on developing innovative cell technologies and systems for liver and pancreas diseases. The company specializes in bioartificial organs and therapeutic cell systems, with its lead product, the HepatAssist Liver Support System, designed to assist patients with acute liver failure. Additionally, Circe is developing the PancreAssist System, an implantable bioartificial pancreas aimed at treating insulin-dependent diabetes. Their products are intended for patients requiring organ support or replacement therapies.Explore more
Popular SearchesCirce Biomedical Inccircebio.comCirce BiomedicalSIC Code 87,873NAICS Code 54,541Show more

Circe Biomedical Org Chart

PhoneEmail
TO

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Circe Biomedical your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Circe Biomedical is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Circe Biomedical is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Circe Biomedical.

Circe Biomedical Tech Stack

Top Business Services Companies

Frequently Asked Questions Regarding Circe Biomedical

What is Circe Biomedical's official website?
Circe Biomedical's official website is www.circebio.com
What is Circe Biomedical's Revenue?
Circe Biomedical's revenue is <$5 Million
What is Circe Biomedical's SIC code?
Circe Biomedical's SIC: 87,873
What is Circe Biomedical's NAICS code?
Circe Biomedical's NAICS: 54,541
How many employees does Circe Biomedical have?
Circe Biomedical has 11-50 employees
What industry does Circe Biomedical belong to?
Circe Biomedical is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What technology does Circe Biomedical use?
Some of the popular technologies that Circe Biomedical uses are: Cloudflare Website Optimization, Cloudflare CDN, ParkingCrew, Cloudflare DNS
Who is the CFO of Circe Biomedical?
Circe Biomedical's CFO is Ted Owens
How do I contact Circe Biomedical?
Circe Biomedical contact info: Phone number: (781) 863-8720 Website: www.circebio.com
What does Circe Biomedical do?

Circe Biomedical is a privately held biomedical company focused on developing innovative cell technologies and systems for liver and pancreas diseases. The company specializes in bioartificial organs and therapeutic cell systems, with its lead product, the HepatAssist Liver Support System, designed to assist patients with acute liver failure. Addit... ionally, Circe is developing the PancreAssist System, an implantable bioartificial pancreas aimed at treating insulin-dependent diabetes. Their products are intended for patients requiring organ support or replacement therapies.Read More

Is Circe Biomedical a public company?
Circe Biomedical is private company therefore does not currently have an official ticker symbol
See more information about Circe Biomedical

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.